山外山收盘上涨2.31%，滚动市盈率69.53倍，总市值51.22亿元

Group 1 - The core viewpoint of the news is that Chongqing Shanwaishan Blood Purification Technology Co., Ltd. has shown a significant increase in stock price and market capitalization, with a current PE ratio of 69.53, which is higher than the industry average of 54.32 [1][3] - As of March 31, 2025, the number of shareholders for the company has increased to 7,938, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company specializes in the research, production, and sales of blood purification equipment and consumables, and has received multiple national awards for its innovations in the field [2] Group 2 - In the latest quarterly report for Q1 2025, the company reported a revenue of 189 million yuan, representing a year-on-year increase of 16.77%, and a net profit of 37.06 million yuan, with a year-on-year growth of 8.10% [2] - The company's gross profit margin stands at 46.72%, indicating a strong profitability in its operations [2] - The company ranks 92nd in the medical device industry based on PE ratio, which reflects its relative valuation compared to peers [1][3]